Physician profile
Suzanne E Higgins
NPI 1578841441
$831.29
in general payments reported to CMS, 2019-2025
11 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.74 · 2022: $133 · 2023: $233 · 2024: $135 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $467.84 | 2022-2025 | Nuzyra |
| Abbvie INC. | $186.55 | 2021-2025 | |
| Smith+Nephew, INC. | $34.82 | 2024-2025 | Renasys Go V2 Home, Collagenase Santyl |
| Organon LLC | $24.59 | 2025 | Nexplanon |
| Kci USA, INC. | $17.99 | 2021 | |
| Insulet Corporation | $17.89 | 2025 | Omnipod |
| Hartmann USA, INC. | $17.71 | 2024 | Zetuvit Plus 10x10 P10 |
| Lilly USA, LLC | $17.51 | 2025 | Zepbound |
| Exact Sciences Corporation | $16.09 | 2023 | Cologuard Collection Kit |
| Acera Surgical, INC. | $15.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.